Status:
UNKNOWN
New Modality for Post Covid Syndrome Patients
Lead Sponsor:
Cairo University
Conditions:
Post Covid Syndrome
Eligibility:
All Genders
30-40 years
Phase:
NA
Brief Summary
Coronavirus (19) is a pandemic that affects many countries allover the world. Many patients experienced symptoms as dyspnea and fatigue after their recovery from coronavirus . These symptoms appear to...
Eligibility Criteria
Inclusion
- age will be ranged from 30 to 40 years
- patients were diagnosed as covid 19 by polymerase chain reaction test using nasopharyngeal swap
- patients will be negative polymerase chain reaction test (pcr) with symptoms of dyspnea and fatigue.
- patients will be recruited after 2 weeks post the negative pcr
- patients who want to participate and complete the study till the end
Exclusion
- patients with photosensitivity
- pacemaker plantation pregnant women
- BMI more than 30kg/m2 infection or inflammation at the site of acupuncture laser malignancy uncontrolled diabetes psychiatric disorders or mental retardation
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05271500
Start Date
March 15 2022
End Date
July 30 2022
Last Update
March 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.